Sunday, November 11, 2018 4:01:32 PM
DALLAS, Oct.25, 2018 /PRNewswire/ - Puration, Inc. (PURA) ("PURA") today announced targeting November 15th as the date for an anticipated 1 for 5 stock dividend to be declared. The company plans to release its 2018 Q3 financial report on or before November 12th and promptly there after announce a formal 1 for 5 stock dividend declaration.
On October 4, 2018, PURA spun off its cannabis cultivation business as part of a strategy to concentrate ongoing business development efforts on the company's flourishing cannabis infused beverage business. The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) ("NOUV"). Specifically, PURA sold its cannabis cultivation business to NOUV in exchange for an NOUV $1.2 million note convertible into common shares of NOUV. The securities exchange agreement included a planned conversion of the purchase debt into NOUV common shares in a sufficient number to support a dividend distribution of NOUV common stock to PURA shareholders in a ratio whereby PURA shareholders receive one share of NOUV for every five shares of PURA that they own.
In addition to PURA's plan to file its 2018 Q3 report on or before November 12th, NOUV management plans to bring NOUV current with its reporting requirements in the same time frame. Accordingly, the two companies plan to cooperate in the declaration of a stock dividend on the November 15th target date whereby PURA shareholders will be eligible to receive one share of NOUV for every five shares of PURA that they own. The two management teams plan to promptly move forward with securing all necessary oversight authorizations and approvals in order payout the dividend as soon as possible after the declaration.
PURA Research Report Speculative Buy Recommendation and $0.25 Target PPS
Goldman Small Cap Research issued a Trade Alert updating its previously issued research report on PURA. The Trade Alert confirmed the previously recommended Speculative Buy and $0.25 Target PPS:
https://www.purationinc.com/goldman-research/
https://www.purationinc.com/trade-alert
About Puration, Inc.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM